1. In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial. (December 2021) Authors: Hamada, Akira; Suda, Kenichi; Koga, Takamasa; Fujino, Toshio; Nishino, Masaya; Ohara, Shuta; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Soh, Junichi; Uchida, Tetsuro; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 162(2021) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells. (February 2017) Authors: Sesumi, Yuichi; Suda, Kenichi; Mizuuchi, Hiroshi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 104(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer. (April 2021) Authors: Ohara, Shuta; Suda, Kenichi; Fujino, Toshio; Hamada, Akira; Koga, Takamasa; Nishino, Masaya; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Soh, Junichi; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 154(2021) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy‐Naive Isogenic Lung Cancer Lesions withEGFRMutation. Issue 10 (October 2016) Authors: Suda, Kenichi; Murakami, Isao; Yu, Hui; Ellison, Kim; Shimoji, Masaki; Genova, Carlo; Rivard, Christopher J.; Mitsudomi, Tetsuya; Hirsch, Fred R. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1). (August 2016) Authors: Shimoji, Masaki; Shimizu, Shigeki; Sato, Katsuaki; Suda, Kenichi; Kobayashi, Yoshihisa; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 98(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study. (December 2018) Authors: Koga, Takamasa; Kobayashi, Yoshihisa; Tomizawa, Kenji; Suda, Kenichi; Kosaka, Takayuki; Sesumi, Yuichi; Fujino, Toshio; Nishino, Masaya; Ohara, Shuta; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Suzuki, Makoto; Jänne, Pasi A.; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 126(2018) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro. (December 2018) Authors: Nishino, Masaya; Suda, Kenichi; Kobayashi, Yoshihisa; Ohara, Shuta; Fujino, Toshio; Koga, Takamasa; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 126(2018) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1). (August 2016) Authors: Shimoji, Masaki; Shimizu, Shigeki; Sato, Katsuaki; Suda, Kenichi; Kobayashi, Yoshihisa; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 98(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer. (October 2017) Authors: Tomizawa, Kenji; Shimizu, Shigeki; Ohara, Shuta; Fujino, Toshio; Nishino, Masaya; Sesumi, Yuichi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Suda, Kenichi; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 112(2017) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic impact of pleural lavage cytology in patients with primary lung cancer. (December 2016) Authors: Tomizawa, Kenji; Nishino, Masaya; Sesumi, Yuichi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Suda, Kenichi; Shimizu, Shigeki; Sato, Takao; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 102(2016) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗